In TRIUMPH-1, the pivotal Phase 3 general-obesity trial (2,339 participants), the topline results reported on May 21, 2026 showed average weight loss at 80 weeks of 19.0% on 4 mg, 25.9% on 9 mg, and 28.3% (70.3 lbs) on 12 mg, versus 2.2% on placebo
With its once-weekly dosing, Semaglutide offers a sustainable, medically-backed solution for those struggling with weight loss
Here, we used human bronchial epithelia (HBE) as a model system due to their importance in defense against inhaled pathogens and particulates [27]
Its also been shown to reduce oiliness and refine skin texture while visibly improving the skins clarity and fine lines
The label is doing a lot of work, and most of it is misleading